Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Fax+1 713-563-6876
Dr. Tang is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2013 - 2017
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2012 - 2013
Stanford University School of MedicineClass of 2012
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2017 - 2028
AZ State Medical License 2023 - 2027
TN State Medical License 2023 - 2027
WA State Medical License 2023 - 2027
GA State Medical License 2023 - 2026
LA State Medical License 2023 - 2026
American Board of Radiology Radiation Oncology- Join now to see all
Clinical Trials
- MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial Start of enrollment: 2020 Aug 19
- Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma Start of enrollment: 2018 Jun 14
Roles: Contact, Principal Investigator
- Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer Start of enrollment: 2019 Nov 20
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Renal Medullary Carcinoma: Utility of [F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment Management.Simone Krebs, Ahmed E Salem, Nghi C Nguyen, Rahul A Sheth, Jose A Karam
Journal of Nuclear Medicine. 2026-06-18 - 1 citationsIntegrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer.Xiaolei Shi, Jarey H Wang, Brian F Chapin, Ana Aparicio, Sumit K Subudhi
Prostate Cancer and Prostatic Diseases. 2026-06-01 - Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Disease: Primary Aggregated Analysis of All Baskets from the Phase II Randomized EXTEND...Alexander D Sherry, Cara Haymaker, Shuqi Wang, Suyu Liu, Tharakeswara K Bathala
Journal of Clinical Oncology. 2026-05-16
Press Mentions
Bladder Cancer Trial “Knocked It Out of the Park,” Expert SaysOctober 1st, 2025- Lutetium-177 with RT Prolongs Survival in Prostate CancerOctober 1st, 2025
- Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual MeetingApril 25th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
